Newsroom
Sorted by: Latest
-
Ant International and HSBC Expand Real-Time Treasury Management Services to the Middle East
ABU DHABI, United Arab Emirates & SINGAPORE--(BUSINESS WIRE)--Ant International announced an expanded collaboration with HSBC to enhance real-time treasury management services in the Middle East....
-
Jonathan Banks, Carly Chaikin, Edwin Hodge, Rhett McLaughlin and Kevin Nealon Hit the Links at 26th Emmys Golf Classic to Raise Over $335,000 for the Television Academy Foundation
LOS ANGELES--(BUSINESS WIRE)--The Television Academy Foundation today announced it raised over $335,000 at the 26th Annual Emmys® Golf Classic held today, Monday, Oct. 5, at the El Caballero Country Club in Tarzana, California. Television stars, sports luminaries, influencers, entertainment industry executives, Television Academy leadership and corporate partners competed in the event, including Jonathan Banks (The Beast in Me), Carlos Bernard (24:Legacy); Carly Chaikin (Mr. Robot), Ambyr Child...
-
HSBC Bank Plc UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- 30-September-2026 Issue: Mitsubishi HC Capital UK Plc Series 973 XS3429235180 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 30-September-2026 Date To: 30-October-2026 Record Date: 27-October-2026 Value Date: 30-October-2026 Benchmark Rate: 3.00518% Margin: 0.33% Total Rate: 3.33518% Floor: 0% Number of Days: 30 Day Count: Actual / 365 (Fixed) Interest Frequency: Monthly Total...
-
NFL Biosciences : point d’étape en vue des prochains jalons créateurs de valeur pour ses deux programmes cliniques dans le sevrage tabagique
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), Montpellier, le 6 octobre 2026, avant ouverture de la Bourse – NFL Biosciences (Euronext Growth Paris – FR0014003XT0 – ALNFL), société biopharmaceutique développant des immunothérapies pour le sevrage tabagique et nicotinique, fait le point sur les avancées de NFL-101 et NFL-102 et précise le calendrier de leurs prochains jalons scientifiques et cliniques. Préparation d’une pub...
-
TotalEnergies SE UK Regulatory Announcement: Transaction in Own Shares
PARIS--(BUSINESS WIRE)-- In accordance with the authorizations given by the shareholders’ general meeting on May 29, 2026, to trade on its shares and pursuant to applicable law on share repurchase, TotalEnergies SE (Paris:TTE) (LSE:TTE) (NYSE:TTE) (LEI: 529900S21EQ1BO4ESM68) declares the following purchases of its own shares (FR0000120271) from September 28 to October 2, 2026: Transaction Date Total daily volume (number of shares) Daily weighted average purchase price of shares (EUR/share) Amo...
-
Wellhub Launches in France, Putting Wellbeing at the Heart of the Employee Value Proposition
PARIS--(BUSINESS WIRE)--Wellhub, a world’s largest corporate wellness platform, today announces its official launch in France. Already operating in 19 countries and used by more than 50,000 companies worldwide, Wellhub is bringing its approach to the French market as wellbeing plays an increasingly important role in employee expectations, HR strategies and the overall employee value proposition. Mental wellbeing, sedentary lifestyles, absenteeism, quality of working life and working conditions...
-
HSBC Bank Plc UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- 05-October-2026 Issue: Mitsubishi HC Capital UK Plc Series 974 XS3436178019 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 09-July-2026 Date To: 09-October-2026 Record Date: 08-October-2026 Value Date: 09-October-2026 Benchmark Rate: 3.68745% Margin: 0.8% Total Rate: 4.48745% Floor: 0% Number of Days: 92 Day Count: Actual / 360 Interest Frequency: Quarterly Total Amount Due: U...
-
Thermo Fisher Scientific Showcases New Solutions and Expanded Capabilities to Accelerate Drug Development at CPHI Milan 2026
MILAN--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, is expanding its drug development, manufacturing, and clinical capabilities to help pharmaceutical and biotechnology companies navigate increasingly complex paths to commercialization, reduce friction, and maintain momentum. The company will showcase these new and expanded capabilities at CPHI Milan 2026, Oct. 6-8. Among the new offerings is OSD Express, a defined solution designed to increase predictability...
-
TotalEnergies SE: Disclosure of Transactions in Own Shares
PARIS--(BUSINESS WIRE)--Regulatory News: In accordance with the authorizations given by the shareholders’ general meeting on May 29, 2026, to trade on its shares and pursuant to applicable law on share repurchase, TotalEnergies SE (Paris:TTE) (LSE:TTE) (NYSE:TTE) (LEI: 529900S21EQ1BO4ESM68) declares the following purchases of its own shares (FR0000120271) from September 28 to October 2, 2026: Transaction Date Total daily volume (number of shares) Daily weighted average purchase price of shares...
-
RoslinCT Awarded £7.25 million Scottish Enterprise R&D Grant to Advance Digital Cell Therapy Manufacturing
EDINBURGH, Scotland--(BUSINESS WIRE)--RoslinCT, a leading global cell therapy Contract Development and Manufacturing Organization (CDMO), today announced it has been awarded a Research & Development grant from Scottish Enterprise to accelerate the digital transformation of its manufacturing operations in Scotland. The funding, supported by a Scottish Enterprise R&D grant of up to £7.25 million, forms part of RoslinCT's ambitious digital expansion plan, a multi-year initiative designed t...